rs369631413
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PP3_Strong
The NM_032043.3(BRIP1):c.1207C>T(p.Arg403Trp) variant causes a missense change. The variant allele was found at a frequency of 0.0000353 in 1,613,330 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_032043.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151956Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 250950Hom.: 0 AF XY: 0.0000737 AC XY: 10AN XY: 135620
GnomAD4 exome AF: 0.0000356 AC: 52AN: 1461374Hom.: 0 Cov.: 32 AF XY: 0.0000413 AC XY: 30AN XY: 726994
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151956Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74178
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:4
The p.R403W variant (also known as c.1207C>T), located in coding exon 8 of the BRIP1 gene, results from a C to T substitution at nucleotide position 1207. The arginine at codon 403 is replaced by tryptophan, an amino acid with dissimilar properties. This alteration has been reported in 2/1824 patients with triple negative breast cancer (Couch FJ et al. J. Clin. Oncol. 2015 Feb;33:304-11) and in 1/118 renal cell carcinoma patients (Smith PS et al. Genes Chromosomes Cancer, 2021 Jan;60:5-16). In another study, this alteration was not detected in 13213 breast cancer cases but was detected in 1/5242 controls (Easton DF et al. J. Med. Genet. 2016 May;53:298-309). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
This missense variant replaces arginine with tryptophan at codon 403 of the BRIP1 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in individuals affected with breast cancer (PMID: 25452441, 33471991), renal cell carcinoma (PMID: 32830346), and unaffected individuals in breast cancer studies (PMID: 26921362, 33471991). This variant has been identified in 13/282352 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
The missense variant NM_032043.3(BRIP1):c.1207C>T (p.Arg403Trp) has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.Arg403Trp variant is observed in 8/113,414 (0.0071%) alleles from individuals of gnomAD Non Finnish European background in gnomAD. The p.Arg403Trp variant is novel (not in any individuals) in 1kG. There is a moderate physicochemical difference between arginine and tryptophan. The gene BRIP1 has a low rate of benign missense variation as indicated by a high missense variants Z-Score of 2.45. The gene BRIP1 contains 18 pathogenic missense variants, indicating that missense variants are a common mechanism of disease in this gene. The p.Arg403Trp missense variant is predicted to be damaging by both SIFT and PolyPhen2. The arginine residue at codon 403 of BRIP1 is conserved in all mammalian species. The nucleotide c.1207 in BRIP1 is predicted conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance. -
- -
not provided Uncertain:2
In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Observed in individuals with breast cancer or renal cell carcinoma, but also in unaffected controls (Couch et al., 2015; Easton et al., 2016; Weber-Lassalle et al., 2018; Moyer et al., 2020; Dorling et al., 2021; Smith et al., 2021); This variant is associated with the following publications: (PMID: 25452441, 26921362, 31822495, 32830346, 33471991, 29368626) -
- -
Familial cancer of breast Uncertain:2
This variant is classified as a variant of uncertain significance as there is insufficient evidence to determine its impact on protein function and/or cancer risk. -
- -
not specified Uncertain:1
Variant summary: BRIP1 c.1207C>T (p.Arg403Trp) results in a non-conservative amino acid change located in the Helicase-like, DEXD box c2 type domain of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4.4e-05 in 250950 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in BRIP1 causing Breast Cancer (4.4e-05 vs 6.3e-05), allowing no conclusion about variant significance. c.1207C>T has been reported in the literature in an individual affected with Breast Cancer (e.g. Couch_2015). These report(s) do not provide unequivocal conclusions about association of the variant with Breast Cancer. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 25452441, 26921362, 29368626). ClinVar contains an entry for this variant (Variation ID: 136141). Based on the evidence outlined above, the variant was classified as uncertain significance. -
Familial cancer of breast;C1836860:Fanconi anemia complementation group J Uncertain:1
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 403 of the BRIP1 protein (p.Arg403Trp). This variant is present in population databases (rs369631413, gnomAD 0.008%). This missense change has been observed in individual(s) with breast cancer and/or renal cell carcinoma (PMID: 25452441, 32830346). ClinVar contains an entry for this variant (Variation ID: 136141). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt BRIP1 protein function with a positive predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Fanconi anemia complementation group J Uncertain:1
- -
Ovarian neoplasm Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at